Literature DB >> 24951465

PDGFRB-rearranged T-lymphoblastic leukemia/lymphoma occurring with myeloid neoplasms: the missing link supporting a stem cell origin.

Sarah L Ondrejka1, Armin G Jegalian1, Annette S Kim2, Devon S Chabot-Richards3, Jennifer Giltnane2, David R Czuchlewski3, Shashirekha Shetty1, Mikkael A Sekeres4, Ashwini Yenamandra2, David Head2, Madan Jagasia5, Eric D Hsi6.   

Abstract

Entities:  

Keywords:  PDGFRB; T-lymphoblastic; leukemia; lymphoma; myeloid neoplasm

Mesh：

Substances：

Year:  2014        PMID： 24951465      PMCID： PMC4562545          DOI： 10.3324/haematol.2014.105452

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  13 in total

1.  Systematic screen for tyrosine kinase rearrangements identifies a novel C6orf204-PDGFRB fusion in a patient with recurrent T-ALL and an associated myeloproliferative neoplasm.

Authors:  Juliann Chmielecki; Martin Peifer; Agnes Viale; Katherine Hutchinson; Jennifer Giltnane; Nicholas D Socci; Clayton J Hollis; Rebecca S Dean; Ashwini Yenamandra; Madan Jagasia; Annette S Kim; Utpal P Davé; Roman K Thomas; William Pao
Journal:  Genes Chromosomes Cancer       Date:  2011-09-21       Impact factor: 5.006

2.  Incidence and clinical characteristics of myeloproliferative neoplasms displaying a PDGFRB rearrangement.

Authors:  Maryam Arefi; Juan L García; María J Peñarrubia; José A Queizán; Lourdes Hermosín; Lucía López-Corral; Marta Megido; Pilar Giraldo; Natalia de las Heras; Raúl J Vanegas; Norma C Gutiérrez; Jesús M Hernández-Rivas
Journal:  Eur J Haematol       Date:  2012-07       Impact factor: 2.997

3.  Tyrosine kinase inhibitor therapy induces remission in a patient with refractory EBF1-PDGFRB-positive acute lymphoblastic leukemia.

Authors:  Brent W Weston; Melissa A Hayden; Kathryn G Roberts; Susan Bowyer; Johann Hsu; George Fedoriw; Kathleen W Rao; Charles G Mullighan
Journal:  J Clin Oncol       Date:  2013-07-08       Impact factor: 44.544

Review 4.  PDGF: the nuts and bolts of signalling toolbox.

Authors:  Ammad Ahmad Farooqi; Salman Waseem; Asma M Riaz; Bilal Ahmed Dilawar; Shahzeray Mukhtar; Sehrish Minhaj; Makhdoom Saad Waseem; Suneel Daniel; Beenish Ali Malik; Ali Nawaz; Shahzad Bhatti
Journal:  Tumour Biol       Date:  2011-07-19

Review 5.  The two faces of myeloproliferative neoplasms: Molecular events underlying lymphoid transformation.

Authors:  Ailsa Holroyd; Nicholas C P Cross; Donald H Macdonald
Journal:  Leuk Res       Date:  2011-07-01       Impact factor: 3.156

6.  Genetic alterations activating kinase and cytokine receptor signaling in high-risk acute lymphoblastic leukemia.

Authors:  Kathryn G Roberts; Ryan D Morin; Jinghui Zhang; Martin Hirst; Yongjun Zhao; Xiaoping Su; Shann-Ching Chen; Debbie Payne-Turner; Michelle L Churchman; Richard C Harvey; Xiang Chen; Corynn Kasap; Chunhua Yan; Jared Becksfort; Richard P Finney; David T Teachey; Shannon L Maude; Kane Tse; Richard Moore; Steven Jones; Karen Mungall; Inanc Birol; Michael N Edmonson; Ying Hu; Kenneth E Buetow; I-Ming Chen; William L Carroll; Lei Wei; Jing Ma; Maria Kleppe; Ross L Levine; Guillermo Garcia-Manero; Eric Larsen; Neil P Shah; Meenakshi Devidas; Gregory Reaman; Malcolm Smith; Steven W Paugh; William E Evans; Stephan A Grupp; Sima Jeha; Ching-Hon Pui; Daniela S Gerhard; James R Downing; Cheryl L Willman; Mignon Loh; Stephen P Hunger; Marco A Marra; Charles G Mullighan
Journal:  Cancer Cell       Date:  2012-08-14       Impact factor: 31.743

7.  Rabaptin-5 is a novel fusion partner to platelet-derived growth factor beta receptor in chronic myelomonocytic leukemia.

Authors:  M K Magnusson; K E Meade; K E Brown; D C Arthur; L A Krueger; A J Barrett; C E Dunbar
Journal:  Blood       Date:  2001-10-15       Impact factor: 22.113

8.  Concurrent acute myeloid leukemia and T lymphoblastic lymphoma in a patient with rearranged PDGFRB genes.

Authors:  Hung Chang; Wen-Yu Chuang; Chien-Feng Sun; Marc R Barnard
Journal:  Diagn Pathol       Date:  2012-02-22       Impact factor: 2.644

9.  Activity of STI571 in chronic myelomonocytic leukemia with a platelet-derived growth factor beta receptor fusion oncogene.

Authors:  Magnus K Magnusson; Kristin E Meade; Ryotaro Nakamura; John Barrett; Cynthia E Dunbar
Journal:  Blood       Date:  2002-08-01       Impact factor: 22.113

Review 10.  Platelet-derived growth factor signaling and human cancer.

Authors:  Jiuhong Yu; Carolyn Ustach; Hyeong-Reh Choi Kim
Journal:  J Biochem Mol Biol       Date:  2003-01-31
View more
  1 in total

1.  Genomic and clinical findings in myeloid neoplasms with PDGFRB rearrangement.

Authors:  Danika Di Giacomo; Martina Quintini; Valentina Pierini; Fabrizia Pellanera; Roberta La Starza; Paolo Gorello; Caterina Matteucci; Barbara Crescenzi; Paolo Fabio Fiumara; Marinella Veltroni; Erika Borlenghi; Francesco Albano; Fabio Forghieri; Monica Maccaferri; Francesca Bettelli; Mario Luppi; Antonio Cuneo; Giuseppe Rossi; Cristina Mecucci
Journal:  Ann Hematol       Date:  2021-12-02       Impact factor: 3.673
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.